Industry Roundup: Supplement GMPs, Walgreens Recall, Healthy Children Study, Homeopathic Comments, Drug Claims
This article was originally published in The Tan Sheet
Executive Summary
Botanicals firm argues GMP intent; Walgreens multivitamin missing child-resistant capsWyeth Nutrition supports NIH healthy children study; homeopathic regulatory evaluation comment period extended; Vitamin Shoppe adds Beardall; and more news in brief.
You may also be interested in...
Health, Beauty And Wellness Industry News: Launches, Appointments, Recall
Non-compliant cap prompts GNC Women’s Iron recall; Pedialyte Sparking Rush takes on sports drinks; ALA, curcumin in latest HydroxyCut formulation; Australian ingrown hair treatments reach US; Canadian cardio health drinks reach US; Sankaran to lead PepsiCo in North America; and Peet’s Coffee invests adjacent kombucha market.
Homeopathic Regulatory Evaluation Stocked With FDA Concerns, Industry Answers
The industry wants FDA to consider that a fraction of poison control reports are for homeopathics compared to other drugs and the agency’s current enforcement authorities maintain compliance in manufacturing and marketing the products. FDA is considering whether to maintain its policy that recognizes an ingredient’s inclusion in the HPUS monograph as pre-market approval.
ChatGPT Unleashed: Generative AI Use Cases Taking Off In Pharma
As generative AI and its star avatar, ChatGPT, take the world by storm, pharma is seeing traction for use cases around smarter pharmacovigilance and commercial marketing content development, among others. Senior executives from Indegene discuss this and more in an interview with Scrip.